Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs J.B.CHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALS ZYDUS LIFESCIENCES/
J.B.CHEMICALS
 
P/E (TTM) x 33.7 48.1 70.0% View Chart
P/BV x 5.7 10.5 54.2% View Chart
Dividend Yield % 0.6 0.6 109.6%  

Financials

 ZYDUS LIFESCIENCES   J.B.CHEMICALS
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
J.B.CHEMICALS
Mar-23
ZYDUS LIFESCIENCES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs4952,150 23.0%   
Low Rs3191,339 23.9%   
Sales per share (Unadj.) Rs170.3407.0 41.8%  
Earnings per share (Unadj.) Rs19.853.0 37.3%  
Cash flow per share (Unadj.) Rs26.967.8 39.7%  
Dividends per share (Unadj.) Rs6.008.88 67.6%  
Avg Dividend yield %1.50.5 289.6%  
Book value per share (Unadj.) Rs173.0304.8 56.8%  
Shares outstanding (eoy) m1,012.2077.38 1,308.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.44.3 55.8%   
Avg P/E ratio x20.632.9 62.5%  
P/CF ratio (eoy) x15.125.7 58.8%  
Price / Book Value ratio x2.45.7 41.1%  
Dividend payout %30.316.7 181.1%   
Avg Mkt Cap Rs m412,144134,983 305.3%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5645,435 452.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37431,493 547.3%  
Other income Rs m4,74699 4,774.6%   
Total revenues Rs m177,12031,592 560.6%   
Gross profit Rs m29,6776,958 426.5%  
Depreciation Rs m7,2271,144 631.7%   
Interest Rs m1,299361 360.3%   
Profit before tax Rs m25,8975,552 466.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8781,452 404.7%   
Profit after tax Rs m20,0194,100 488.3%  
Gross profit margin %17.222.1 77.9%  
Effective tax rate %22.726.2 86.8%   
Net profit margin %11.613.0 89.2%  
BALANCE SHEET DATA
Current assets Rs m100,08215,993 625.8%   
Current liabilities Rs m55,2676,257 883.3%   
Net working cap to sales %26.030.9 84.1%  
Current ratio x1.82.6 70.8%  
Inventory Days Days5085 59.1%  
Debtors Days Days94667 14.0%  
Net fixed assets Rs m144,77624,988 579.4%   
Share capital Rs m1,012155 653.9%   
"Free" reserves Rs m174,14623,433 743.2%   
Net worth Rs m175,15823,587 742.6%   
Long term debt Rs m03,832 0.0%   
Total assets Rs m244,94040,981 597.7%  
Interest coverage x20.916.4 127.7%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.70.8 91.6%   
Return on assets %8.710.9 80.0%  
Return on equity %11.417.4 65.8%  
Return on capital %15.521.6 72.0%  
Exports to sales %39.240.6 96.6%   
Imports to sales %11.917.5 68.2%   
Exports (fob) Rs m67,57712,784 528.6%   
Imports (cif) Rs m20,5445,500 373.5%   
Fx inflow Rs m67,57712,784 528.6%   
Fx outflow Rs m20,5445,500 373.5%   
Net fx Rs m47,0337,284 645.7%   
CASH FLOW
From Operations Rs m26,8886,256 429.8%  
From Investments Rs m11,712-9,618 -121.8%  
From Financial Activity Rs m-44,0043,565 -1,234.2%  
Net Cashflow Rs m-5,338204 -2,617.9%  

Share Holding

Indian Promoters % 75.0 0.0 -  
Foreign collaborators % 0.0 53.8 -  
Indian inst/Mut Fund % 18.0 28.9 62.4%  
FIIs % 5.0 10.4 48.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 46.2 54.2%  
Shareholders   306,495 63,230 484.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    SUPRIYA LIFESCIENCE     


More on Cadila Healthcare vs J.B.Chemicals

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs J.B.Chemicals Share Price Performance

Period Cadila Healthcare J.B.Chemicals S&P BSE HEALTHCARE
1-Day -0.80% -1.07% -0.92%
1-Month 8.24% -3.72% -4.98%
1-Year 106.49% 62.92% 57.53%
3-Year CAGR 32.18% 38.66% 18.16%
5-Year CAGR 23.84% 57.37% 18.89%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the J.B.Chemicals share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of J.B.Chemicals the stake stands at 53.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of J.B.Chemicals.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

J.B.Chemicals paid Rs 8.9, and its dividend payout ratio stood at 16.7%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of J.B.Chemicals.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.